Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
Titel:
Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
Auteur:
Vansteenkiste, J. Barlesi, F. Waller, C.F. Bennouna, J. Gridelli, C. Goekkurt, E. Verhoeven, D. Szczesna, A. Feurer, M. Milanowski, J. Germonpre, P. Lena, H. Atanackovic, D. Krzakowski, M. Hicking, C. Straub, J. Picard, M. Schuette, W. O'Byrne, K.